Buparvaquone Nanostructured Lipid Carrier: Development of an Affordable Delivery System for the Treatment of Leishmaniases

Buparvaquone (BPQ), a veterinary drug, was formulated as nanostructured lipid carriers (NLC) for leishmaniases treatment. The formulation design addressed poor water solubility of BPQ and lack of human drug delivery system. The DSC/TG and microscopy methods were used for solid lipids screening. Soft...

Descripción completa

Detalles Bibliográficos
Autores principales: Monteiro, Lis Marie, Löbenberg, Raimar, Cotrim, Paulo Cesar, Barros de Araujo, Gabriel Lima, Bou-Chacra, Nádia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5309432/
https://www.ncbi.nlm.nih.gov/pubmed/28255558
http://dx.doi.org/10.1155/2017/9781603

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5309432/
https://www.ncbi.nlm.nih.gov/pubmed/28255558
http://dx.doi.org/10.1155/2017/9781603

Ejemplares similares